Kusatsu/Shiga, Japan – January 14, 2016 – The Board of Directors resolved today that its consolidated subsidiary, United States-based Clontech Laboratories, Inc. has changed the company name in January 2016 as follows.
1. Overview of the consolidated subsidiary
|Clontech Laboratories, Inc.Takara Bio USA, Inc.|
|Address||1290 Terra Bella Avenue Mountain View, CA 94043|
|President||President, Carol Lou|
|Business outline||Development and sales of research reagents|
|Capital||83,000 US dollars|
2. Reason for the change
Takara Bio develops original three brands, “TaKaRa®”, “Clontech®”, and “Cellartis®” in the world’s bioindustry business for research reagents, scientific instruments, and contracted research services. The current change of the company name will enable to reinforce “Clontech®” as a brand of products and services and increase global awareness of Takara Bio.